Skip to content

Withdraw due to duplicate registration. Pain management after conservative treatment of limb fracture - a double-blind randomized controlled trial

Pain management after conservative treatment of limb fracture - a double-blind randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014596
Enrollment
Unknown
Registered
2018-01-23
Start date
2018-02-05
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

extremities fracture

Interventions

A group:The patients were treated on their own by taking acetaminophen tablets (325mg acetaminophen + 5mg oxycodone), and routinely giving pain management and education on the dosage
B group:The patients were treated on their own by taking paracetamol tablets (500mg acetaminophen), and routinely giving pain management and education on the dosage

Sponsors

Shanghai Jiaotong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) complaint of acute pain of less than seven days duration; 2) location of pain in one or more extremities defined as distal to and including the shoulder joint in the upper extremities and distal to and including the hip joint in the lower extremities; 3) radiologic evaluation is planned; 4) limb fractures, conservative treatment; 5) aged 18-100 years of age, gender is not limited; 6) informed consent and signed informed consent.

Exclusion criteria

Exclusion criteria: 1) accompanied by other non-limb fractures; 2) accompanied by blood vessels, nerves, tendon injury; 3) open fractures; 4) chronic condition requiring frequent pain management such as sickle cell disease, fibromyalgia, or any neuropathy 5) past use of methadone; 6) history of an adverse reaction to any of the study medications; 7) history of peptic ulcer; 8) report of any prior use of recreational narcotics; 9) medical condition that might affect metabolism of opioid analgesics, acetaminophen, or ibuprofen such as hepatitis, renal insufficiency or failure, hypo- or hyperthyroidism, Addisons or Cushings disease; 10) taking any medicine that might interact with one of the study medications, such as antidepressant SSRIs or Tricyclics, antipsychotics, anti-malaria medications quinidine or halofantrine, Amiodarone or Dronedarone, diphenhydramine, celecoxib, ranitidine, cimetidine, ritanovir, terbinafine, or St Johns Wort; 11) accompanied by mental illness history, dementia, etc. can not be normal, accurate communication and answer questions; 12) physically handicapped; incapacitated; 13) do not want or can not cooperate with the data collector; 14) maternal and other incompatible persons.

Design outcomes

Primary

MeasureTime frame
NRS score;

Secondary

MeasureTime frame
Anxiety and depression scale;EQ-5d Quality of Life Scale;Satisfaction with analgesia (0-10 points);Changes in sleep time;

Countries

China

Contacts

Public ContactXianyou Zheng

Shanghai Jiaotong University Affiliated Sixth People's Hospital

zhengxianyou@126.com+86 13916180968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026